Search for a command to run...
Amwill Health Care Ltd. appears to be underperforming relative to its peers in terms of growth and profitability metrics. However, it presents a low valuation with a PE of 10.61, making it a potential value pick but with significant risks due to its lack of growth and profitability compared to peers. Companies like Sun Pharmaceutical Industries and Dr. Reddy's Laboratories showcase strong profitability and growth, positioning them as sector leaders.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Amwill Health Care Ltd. | ₹56.93 | ₹113.88Cr | 10.61 | - | - |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |